Literature DB >> 24418744

Antiretropulsion devices.

Fernando J Cabrera1, Glenn M Preminger, Michael E Lipkin.   

Abstract

PURPOSE OF REVIEW: Stone migration during the treatment of ureteral stones can prove frustrating and increases both healthcare cost and patient morbidity. Antiretropulsion devices have been engineered to prevent stone migration. RECENT
FINDINGS: Improvements in antiretropulsion devices allow for efficient prevention of stone migration during ureteroscopic lithotripsy with minimal adverse effects or complications. Multiple devices are now available each with advantages and disadvantages. New devices are currently engineered to prevent stone migration and maintain ureteral access. Antiretropulsion devices appear to be cost-effective to prevent stone migration during intracorporeal lithotripsy.
SUMMARY: Antiretropulsion devices have been safely and effectively used during ureteroscopic procedures. These tools increase stone-free rates, decrease morbidity and new studies have demonstrated their cost-effectiveness.

Entities:  

Mesh:

Year:  2014        PMID: 24418744     DOI: 10.1097/MOU.0000000000000032

Source DB:  PubMed          Journal:  Curr Opin Urol        ISSN: 0963-0643            Impact factor:   2.309


  3 in total

Review 1.  Update of the ICUD-SIU consultation on stone technology behind ureteroscopy.

Authors:  Jonathan Cloutier; Ken Anson; Guido Giusti; Michael Grasso; Guido Kamphuis; Sven Lahme; Evangelos Liatsikos; Anup Patel; Margaret S Pearle; Luc Valiquette; Olivier Traxer
Journal:  World J Urol       Date:  2017-07-25       Impact factor: 4.226

2.  Use of a modified ureteral access sheath in semi-rigid ureteroscopy to treat large upper ureteral stones is associated with high stone free rates.

Authors:  Jad Khaled AlSmadi; Xiaohang Li; Guohua Zeng
Journal:  Asian J Urol       Date:  2019-01-07

3.  Suctioning semirigid ureteroscopic lithotomy versus minimally invasive percutaneous nephrolithotomy for large upper ureteral stones: a retrospective study.

Authors:  Hequn Chen; Zewu Zhu; Yu Cui; Yang Li; Zhiyong Chen; Zhongqing Yang; Feng Zeng
Journal:  Transl Androl Urol       Date:  2021-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.